Chordia Therapeutics

190A.TPharmaceutical
Filed as Chordia Therapeutics Inc. (2024-07–2026-04)
Major holders (5%+) · 6
HolderStakeChangeFiled
Nomura Securities Co., Ltd.20.05%+19.37pp2026-09-16
Takeda Pharmaceutical Company Limited16.42%—2024-06-20
SBI SECURITIES Co., Ltd.13.87%-2.53pp2026-09-16
Shinsei Capital Partners, Ltd.11.06%—2024-06-21
SBI Investment Co., Ltd.6.63%-2.10pp2024-07-30
MIYAKE HIROSHI5.73%—2024-06-21

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 8
-4.85%2025-04-25
Kyoto University Innovation Capital Co., Ltd.4.68%2026-05-14
JAFCO Group Co., Ltd.4.53%2024-10-18
SMBC Venture Capital Co., Ltd4.51%2024-10-03
UTokyo Innovation Platform Co., Ltd.3.77%2024-09-27
Nomura SPARX Investment, Inc.2.61%2026-09-16
NOMURA INTERNATIONAL PLC0.16%2026-09-16
Sumitomo Mitsui DS Asset Management Company, Limited0.00%2024-09-24
Ownership history · 58
FiledHolderRatioChangePurpose
2024-06-21AmendedJAFCO Group Co., Ltd.2024-06-21 · amended7.32%newPure investment
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.00%+0.14ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended8.86%-2.69ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended4.86%-0.67ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended11.55%-1.08ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.53%-0.07ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended12.63%-1.17ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.60%-0.09ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended13.80%-1.38ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.69%-0.08ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended15.18%-0.91ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.77%-0.09ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended16.09%-1.01ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.86%-0.09ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended17.10%-1.15ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended5.95%-0.07ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended18.25%-1.10ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended6.02%-0.08ppPure investment
2024-06-21AmendedSBI SECURITIES Co., Ltd.2024-06-21 · amended19.35%-0.94ppSecurities trading business
2024-06-21AmendedSBI Investment Co., Ltd.2024-06-21 · amended6.10%-0.14ppPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.